POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 86 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,920,774 | +48.3% | 1,227,216 | +9.7% | 0.00% | – |
| Q2 2023 | $1,969,009 | +172.7% | 1,118,755 | +377.1% | 0.00% | – |
| Q1 2023 | $722,158 | -56.8% | 234,467 | -25.6% | 0.00% | – |
| Q4 2022 | $1,670,210 | +409.2% | 315,134 | +239.0% | 0.00% | – |
| Q3 2022 | $328,000 | +36.7% | 92,967 | 0.0% | 0.00% | – |
| Q2 2022 | $240,000 | -89.9% | 92,967 | -82.5% | 0.00% | – |
| Q1 2022 | $2,381,000 | -35.7% | 531,573 | -2.3% | 0.00% | – |
| Q4 2021 | $3,704,000 | -2.6% | 543,932 | +4.3% | 0.00% | – |
| Q3 2021 | $3,802,000 | -26.2% | 521,513 | +1.5% | 0.00% | – |
| Q2 2021 | $5,150,000 | +19.4% | 513,992 | +13.8% | 0.00% | – |
| Q1 2021 | $4,314,000 | +110.5% | 451,678 | +141.8% | 0.00% | – |
| Q4 2020 | $2,049,000 | +75.4% | 186,799 | +41.9% | 0.00% | – |
| Q3 2020 | $1,168,000 | – | 131,648 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 3,567,985 | $8,491,804 | 2.58% |
| Aisling Capital Management LP | 1,043,267 | $2,482,975 | 1.02% |
| Atom Investors LP | 156,168 | $371,680 | 0.08% |
| Pentwater Capital Management LP | 5,975,000 | $14,220,500 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 79,709 | $189,707 | 0.04% |
| Forefront Analytics, LLC | 24,969 | $59,428 | 0.03% |
| Callan Capital, LLC | 76,559 | $182,210 | 0.02% |
| XTX Topco Ltd | 40,782 | $97,061 | 0.02% |
| Advisory Services Network, LLC | 257,271 | $612,305 | 0.02% |
| RBF Capital, LLC | 70,171 | $167,007 | 0.01% |